Fortis Healthcare Ltd

BSE: FORTIS532843ISIN INE061F01013

Healthcare
Hospital
BSE 200

BSE listing

Share price

₹875.00-12.25 (-1.38%)

as of 18 Sep 2026

52W high: ₹1,105.00
52W low: ₹767.30
Off 52W high: -20.81%
1M return: -3.93%
3M return: -9.13%
6M return: +6.51%
1Y return: -9.63%
20D avg volume: 1,39,865
50 DMA: ₹926.97
200 DMA: ₹911.96

Key ratios Consolidated

Market cap: ₹66,059 Cr
Current price: ₹875.00
52W high / low: ₹1,105.00 / ₹767.30
Face value: ₹10.00
P/E: 61.73
P/B: —
EPS (TTM): ₹14.18
Book value / share: —
ROE: —
ROCE: 12.00%
Operating margin: —
Net margin: —
Debt / equity: 0.28
Net debt: ₹2,466 Cr
Interest cover: 5.29
Dividend yield: 0.11%
Dividend / share (TTM): ₹1.00
Payout: 7.05%
Cash conversion cycle: 9.4 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	2,545	2,365	2,265	2,331	2,167	2,007	1,928	1,988	1,859	1,786	1,680	1,770
	14.47	4.39	8.29	22.58	15.40	19.80	20.89	13.24	13.01	9.80	6.81	13.50
	2,210	2,039	1,965	1,956	1,847	1,742	1,696	1,685	1,643	1,532	1,516	1,556
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	585.57	520.72	522.23	547.84	517.86	459.58	457.41	465.76	455.32	402.63	388.81	416.18
	404.43	339.68	327.58	316.62	312.75	287.29	294.24	290.32	295.39	271.54	282.08	281.38
	80.44	84.28	85.74	74.88	69.57	67.56	45.15	36.43	35.27	34.69	32.96	31.81
	121.88	121.97	120.14	105.84	101.48	102.23	97.33	95.05	91.00	92.23	86.91	84.12
	1,031	973.79	915.64	918.93	849.20	821.42	391.66	393.57	374.65	349.86	357.21	372.08
	349.27	330.47	308.06	398.19	335.02	285.48	253.53	316.59	229.26	263.92	170.91	227.74
	9.53	-12.49	-45.91	23.53	12.63	-53.57	23.80	-59.77	0.20	3.14	7.71	3.69
	358.80	317.98	262.15	421.72	347.65	231.91	277.33	256.82	229.46	267.06	178.62	231.43
	90.38	53.01	68.28	96.58	83.79	48.53	25.09	67.97	56.07	68.24	48.92	48.81
	272.80	271.19	197.40	328.82	266.78	188.02	254.30	193.08	173.98	203.14	134.23	183.90
	3.53	3.52	2.57	4.26	3.45	2.44	3.28	2.34	2.20	2.37	1.78	2.30
Key metrics
	561.12	524.23	468.03	602.44	518.70	401.70	419.81	388.30	355.73	393.98	298.49	347.36
	22.00%	22.20%	20.70%	25.80%	23.90%	20.00%	21.80%	19.50%	19.10%	22.10%	17.80%	19.60%
	10.70%	11.50%	8.70%	14.10%	12.30%	9.40%	13.20%	9.70%	9.40%	11.40%	8.00%	10.40%
	—	2.90%	—	3.70%	—	2.50%	—	—	—	—	—	—
	17.50%	17.80%	17.50%	17.30%	16.60%	12.40%	14.80%	12.30%	—	—	—	—
	2.30%	44.20%	-22.40%	70.30%	53.30%	-7.40%	89.50%	5.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	9,506	9,128	7,783	6,893	6,298	5,718	4,030	4,632	4,469	4,561
	49.73	50.66	66.94	38.25	61.72	27.34	46.56	52.64	92.40	139.73
	8,170	7,807	6,765	6,099	5,641	5,096	4,082	4,520	4,814	4,784
	0.00	0.00	0.00	—	—	—	975.90	963.85	928.24	999.02
	2,176	2,109	1,838	1,603	1,455	1,403	—	—	—	—
	1,388	1,297	1,167	1,120	1,047	972.94	849.01	916.03	913.59	905.65
	325.34	314.47	184.41	130.95	129.09	146.85	165.88	205.06	336.83	257.79
	469.83	449.43	385.61	342.50	315.74	300.84	290.60	291.73	232.92	—
	3,839	3,658	3,197	1,428	1,383	1,217	991.80	1,167	1,214	1,434
	1,386	1,372	1,085	832.44	718.23	648.61	-5.48	165.37	-252.13	-83.90
	-25.34	-22.24	-89.34	16.02	73.61	315.03	1.21	61.83	-222.38	-881.03
	1,361	1,350	995.52	848.46	791.84	963.64	-4.27	227.20	-474.51	-964.93
	308.25	301.66	197.66	212.75	180.70	197.84	99.46	147.87	113.61	22.65
	1,070	1,064	809.38	645.22	632.98	789.95	-56.17	91.49	-223.71	-934.42
	13.88	13.80	10.26	7.93	7.80	7.35	-1.45	0.77	-3.70	—
Key metrics
	2,156	2,113	1,566	1,322	1,237	1,411	452.21	723.99	95.24	-707.14
	22.68%	23.20%	20.10%	19.20%	19.60%	24.70%	11.20%	15.60%	2.10%	-15.50%
	11.26%	11.70%	10.40%	9.40%	10.10%	13.80%	-1.40%	2.00%	-5.00%	-20.50%
	—	12.00%	9.80%	—	—	—	—	—	—	—
	—	17.30%	12.90%	9.50%	10.10%	41.90%	-13.00%	3.60%	-2.00%	—
	—	31.50%	25.40%	1.90%	-19.90%	1,506.40%	-161.40%	140.90%	76.10%	—
	—	656.27	576.99	—	—	—	—	—	—	—
	—	1.51	1.76	—	—	—	—	—	—	—
	—	0.28	0.27	—	—	—	—	—	—	—
	—	2,466	2,335	—	—	—	—	—	—	—
	—	9.4	4.3	—	—	—	—	—	—	—
Balance sheet
	—	15,966	13,692	—	—	—	—	—	—	—
	—	1,819	2,164	—	—	—	—	—	—	—
	—	406.97	139.72	—	—	—	—	—	—	—
	—	1,044	784.49	—	—	—	—	—	—	—
	—	135.27	115.30	—	—	—	—	—	—	—
	—	—	51.03	—	—	—	—	—	—	—
	—	5,348	5,848	—	—	—	—	—	—	—
	—	943.12	807.62	—	—	—	—	—	—	—
	—	2,121	1,607	—	—	—	—	—	—	—
	—	2,873	2,475	—	—	—	—	—	—	—
	—	471.49	163.78	—	—	—	—	—	—	—
	—	2,401	2,311	—	—	—	—	—	—	—
	—	10,169	9,169	—	—	—	—	—	—	—
Cash flow
	—	1,602	1,424	—	—	—	—	—	—	—
	—	-1,538	-779.38	—	—	—	—	—	—	—
	—	163.76	-713.84	—	—	—	—	—	—	—
	—	945.53	846.94	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	489.45	460.73	442.93	455.81	433.03	388.47	366.87	357.15	333.40	307.48	290.75	294.12
	18.92	16.53	16.22	92.42	40.01	24.99	33.96	104.17	35.43	32.50	31.67	48.23
	462.36	427.82	429.45	435.08	426.95	399.94	355.58	341.03	318.33	282.47	286.63	300.40
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	117.21	98.11	109.24	118.14	116.31	98.93	95.97	96.92	92.07	77.36	80.90	76.42
	75.92	64.26	61.30	60.14	61.90	55.05	51.52	51.38	49.18	46.01	45.65	46.20
	46.86	47.54	55.66	50.67	51.87	51.91	26.51	16.32	16.84	18.44	19.37	20.81
	29.98	29.86	29.62	28.48	30.16	30.52	28.96	27.41	26.03	25.85	25.25	25.08
	197.58	186.13	176.10	179.10	169.39	164.13	81.35	86.55	75.83	60.14	45.49	58.11
	46.01	49.44	29.70	113.15	46.09	13.52	45.25	120.29	50.50	57.51	35.79	41.95
	13.30	-12.07	4.48	21.83	16.88	-52.42	5.56	-68.28	—	32.10	—	61.55
	59.31	37.37	34.18	134.98	62.97	-38.90	50.81	52.01	50.50	89.61	35.79	103.50
	11.53	12.39	5.78	9.89	11.09	3.33	11.25	12.38	23.67	21.28	12.85	8.20
	47.78	24.98	28.40	125.09	51.88	-42.23	39.56	39.63	26.83	68.33	22.94	95.30
	0.63	0.33	0.38	1.65	0.69	-0.56	0.52	0.52	0.36	0.90	0.30	1.26
Key metrics
	136.15	114.77	119.46	214.13	145.00	43.53	106.28	95.74	93.37	133.90	80.41	149.39
	27.80%	24.90%	27.00%	47.00%	33.50%	11.20%	29.00%	26.80%	28.00%	43.50%	27.70%	50.80%
	9.80%	5.40%	6.40%	27.40%	12.00%	-10.90%	10.80%	11.10%	8.00%	22.20%	7.90%	32.40%
	—	0.80%	—	1.70%	—	0.10%	—	—	—	—	—	—
	13.00%	18.60%	20.70%	27.60%	29.90%	26.30%	26.20%	21.40%	—	—	—	—
	-7.90%	159.20%	-28.20%	215.60%	93.40%	-161.80%	72.40%	-58.40%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	1,849	1,792	1,446	1,181	1,053	862.61	632.87	701.85	656.49	659.48
	144.09	165.18	198.55	143.00	149.57	134.10	191.98	938.34	524.49	137.89
	1,755	1,719	1,415	1,172	1,142	989.42	857.18	890.88	1,001	789.72
	0.00	0.00	0.00	—	—	—	150.58	147.47	131.69	135.56
	442.70	441.80	383.89	309.07	266.40	209.30	—	—	—	—
	261.62	247.60	207.13	187.98	175.45	154.23	147.65	155.44	—	—
	200.73	205.74	111.58	81.92	106.24	129.58	141.45	160.17	192.27	63.74
	117.94	118.12	112.92	100.98	115.88	112.63	110.78	96.81	—	—
	738.91	710.74	603.15	279.59	—	168.77	156.10	154.78	247.80	176.54
	238.30	238.37	229.56	152.91	60.59	7.29	-32.33	749.31	179.64	7.65
	27.54	31.12	-115.14	93.65	48.29	-16.28	56.46	-128.63	—	-67.95
	265.84	269.49	114.42	246.56	108.88	-8.99	24.13	620.68	179.64	-60.30
	39.59	39.15	50.63	47.11	12.64	4.26	19.93	107.35	56.56	3.43
	226.25	230.34	63.79	199.45	96.24	-13.25	4.20	513.33	123.08	-63.73
	2.99	3.05	0.84	2.64	1.27	-0.18	0.06	6.80	2.02	—
Key metrics
	584.51	593.35	338.92	429.46	331.00	233.22	276.36	877.66	371.91	3.44
	31.61%	33.10%	23.40%	36.40%	31.40%	27.00%	43.70%	125.00%	56.70%	0.50%
	12.24%	12.90%	4.40%	16.90%	9.10%	-1.50%	0.70%	73.10%	18.70%	-9.70%
	—	4.30%	2.10%	—	—	—	—	—	—	—
	—	24.00%	22.40%	12.20%	22.10%	36.30%	-9.80%	6.90%	-0.50%	—
	—	261.10%	-68.00%	107.20%	826.30%	-415.50%	-99.20%	317.10%	293.10%	—
	—	-191.15	-31.17	—	—	—	—	—	—	—
	—	0.50	5.24	—	—	—	—	—	—	—
	—	0.21	0.22	—	—	—	—	—	—	—
	—	1,967	1,990	—	—	—	—	—	—	—
	—	-44.1	-119.0	—	—	—	—	—	—	—
Balance sheet
	—	11,994	11,999	—	—	—	—	—	—	—
	—	332.82	482.82	—	—	—	—	—	—	—
	—	3.89	48.96	—	—	—	—	—	—	—
	—	239.81	181.32	—	—	—	—	—	—	—
	—	21.41	16.72	—	—	—	—	—	—	—
	—	—	7.93	—	—	—	—	—	—	—
	—	967.82	891.49	—	—	—	—	—	—	—
	—	477.92	669.51	—	—	—	—	—	—	—
	—	1,009	994.70	—	—	—	—	—	—	—
	—	1,971	2,039	—	—	—	—	—	—	—
	—	280.64	137.63	—	—	—	—	—	—	—
	—	1,691	1,901	—	—	—	—	—	—	—
	—	9,229	9,074	—	—	—	—	—	—	—
Cash flow
	—	116.12	334.02	—	—	—	—	—	—	—
	—	11.31	-1,572	—	—	—	—	—	—	—
	—	-176.29	1,276	—	—	—	—	—	—	—
	—	307.27	365.19	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +19.40%
Sales CAGR 5Y: +23.15%
Sales CAGR 10Y: —
Profit CAGR 3Y: +33.76%
Profit CAGR 5Y: +122.75%
Profit CAGR 10Y: —
Sales YoY (TTM): +19.63%
Profit YoY (TTM): +154.67%

Consolidated

Sales CAGR 3Y: +13.17%
Sales CAGR 5Y: +17.76%
Sales CAGR 10Y: —
Profit CAGR 3Y: +18.91%
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): +17.50%
Profit YoY (TTM): +18.62%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 31.17%

Holder	Type	Holding	Previous	Change
NORTHERN TK VENTURE PTE. LTD.	Promoter	31.17%	—	—
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND	Public	6.54%	—	—
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE	Public	5.76%	—	—
REKHA JHUNJHUNWALA	Public	4.02%	—	—
AXIS MUTUAL FUND TRUSTEE LTD. A/C AXIS MUTUAL FUND	Public	2.94%	—	—
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA NIF	Public	2.50%	—	—
SBI LIFE INSURANCE CO. LTD	Public	1.73%	—	—
AMANSA HOLDINGS PRIVATE LIMITED	Public	1.61%	—	—
DSP NIFTY MIDCAP 150 ETF	Public	1.44%	—	—
EDELWEISS TRUSTEESHIP CO LTD AC- EDELWEISS MF AC-	Public	1.24%	—	—
HDFC LIFE INSURANCE COMPANY LIMITED	Public	1.22%	—	—
AXIS BANK LIMITED	Public	1.19%	—	—
KOTAK FUNDS - INDIA MIDCAP FUND	Public	1.13%	—	—
JUPITER INDIA FUND	Public	1.13%	—	—
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C	Public	1.09%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

The relevant disclosure is attached.16 Sep 2026 · Company Update / Press Release / Media Release
The relevant disclosure is attached.16 Sep 2026 · Company Update / General
The relevant disclosure is attached.16 Sep 2026 · Company Update / General
The Relevant Disclosure is Attached.15 Sep 2026 · Company Update / Analyst / Investor Meet
The Relevant Disclosure is Attached.15 Sep 2026 · Company Update / Analyst / Investor Meet
The relevant disclosure is attached.11 Sep 2026 · Company Update / General
The relevant disclosure is attached.10 Sep 2026 · Company Update / Earnings Call Transcript
The revised Intimation is attached.9 Sep 2026 · Company Update / Analyst / Investor Meet
The revised Intimation is attached.9 Sep 2026 · Company Update / Analyst / Investor Meet
The relevant disclosure is attached9 Sep 2026 · Company Update / Analyst / Investor Meet
The relevant disclosre is attached.9 Sep 2026 · Company Update / Analyst / Investor Meet
The Relevant disclosure is attached.4 Sep 2026 · Company Update / Analyst / Investor Meet
The Relevant Disclosure is Attached.1 Sep 2026 · Company Update / Analyst / Investor Meet
Relevant disclosure is attached.1 Sep 2026 · Company Update / General
The relevant disclosure is attached.24 Aug 2026 · Company Update / General
Relevant disclosure attached11 Aug 2026 · Company Update / Earnings Call Transcript
Relevant disclosure attached11 Aug 2026 · AGM/EGM / AGM
The relevant disclosure is attached.11 Aug 2026 · AGM/EGM / AGM
Proceeding of 30th Annual General Meeting11 Aug 2026 · AGM/EGM / AGM
Relevant disclosure is attached7 Aug 2026 · Company Update / Newspaper Publication
Relevant disclosure is attached7 Aug 2026 · Company Update / Analyst / Investor Meet
The relevant disclosure is attached.6 Aug 2026 · Company Update / Investor Presentation
The relevant disclosure is attached.6 Aug 2026 · Company Update / Press Release / Media Release
Appointment of Tax Auditor6 Aug 2026 · Company Update / Change in Management
The Relevant disclosure is attached6 Aug 2026 · Result / Financial Results
The relevant disclosure is attached6 Aug 2026 · Board Meeting / Outcome of Board Meeting
The relevant disclosure is attached.5 Aug 2026 · Company Update / General
Relevant disclosure is attached31 Jul 2026 · Company Update / Analyst / Investor Meet
Relevant Disclosure is attached30 Jul 2026 · Company Update / Analyst / Investor Meet
Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve the Un-audited financial ....30 Jul 2026 · Board Meeting / Board Meeting
Relevant disclosure is attached.21 Jul 2026 · Company Update / General
Agilus Diagnostics Limited(Subsidiary of the Company) appoints Vijender Singh as Managing Director and Chief Executive Officer20 Jul 2026 · Company Update / Press Release / Media Release
The relevant disclosure is attached.18 Jul 2026 · Company Update / Newspaper Publication
Company has fixed the closure of Register of Menbers17 Jul 2026 · Corp. Action / Book Closure
Company has fix the Record date for payment of Dividend17 Jul 2026 · Corp. Action / Record Date
Letters sent to the shareholders containing the weblink to access the Annual Report FY 2025-202617 Jul 2026 · Company Update / General
Bussiness Resposibilty and Sustainability report for FY 2025-202617 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report for FY 2025-202617 Jul 2026 · Others
Annual Report for FY 2025-202617 Jul 2026 · Others / Reg. 34 (1) Annual Report
Notice of Annual General Meeting17 Jul 2026 · AGM/EGM / AGM

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.0000	24 Jul 2026	24 Jul 2026	—
Final Dividend - Rs. - 1.0000	25 Jul 2025	25 Jul 2025	—
Final Dividend - Rs. - 1.0000	24 Jul 2024	24 Jul 2024	—

Board meetings

6 Aug 2026 Board Meeting - Financial Results